Daicel Chiral Technologies (India) Pvt Ltd (DCTI) is an Indian subsidiary of Japan based Daicel Corporation, the global leader in Chiral Chromatography. DCTI was established at IKP Knowledge Park, Genome Valley, Hyderabad in 2008 to support Indian Pharmaceutical Industry in the field of chiral chromatography. DCTI’s chiral applications and contract chiral separation services using prep HPLCs and prep SFCs are highly valued by Indian Pharmaceutical Industry. Later, DCTI has established its new business vertical, Pharma Services, to support Indian and global companies. Pharma Services includes GMP Analytical Services, Purification services and Synthesis Services. GMP Analytical Services division had successful inspections from the US-FDA in 2016 and 2019. DCTI also possesses ISO 9001-2015 QMS certification by DNV-GL; ISO-17025 accreditation and CDSCO & DCA approval for commercial testing. Analytical Method Development, Analytical Method Validations, Trace Analysis, In-vitro bio equivalence studies, Extractables & Leachables Studies, Stability Studies, Microbiology Studies, Analysis of Peptides, Release Testing services, etc are offered under GMP Analytical Services. Purification services ranging from few grams to multi Kg scale are offered under cGMP and developmental GMP environments. Impurity isolation and characterization services are also offered. Synthesis Services includes customs synthesis of Pharma Impurity Standards, Stable isotope labeled internal standards, Custom peptide synthesis and Peptide process development services. DCTI has been closely working with its parent company in Japan and sister companies: Chiral Tech.(CTI), USA & Chiral Tech. Europe (CTE), France to bring new technologies to serve Indian Pharma Industry. In view of innovative solutions being offered, DCTI has become the preferred partner for Pharma industry. DCTI created state-of-the-art world-class facility DCTI Knowledge Centre to offer high value & integrated services under one roof.